Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.774716
Title: A study of succinate dehydrogenase deficient tumourigenesis : from functional assessment of variant pathogenicity to the discovery of new disease biomarkers
Author: Casey, Ruth
ISNI:       0000 0004 7961 9198
Awarding Body: University of Cambridge
Current Institution: University of Cambridge
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
A loss of function of the citric acid cycle enzyme complex succinate dehydrogenase (SDH) is associated with a predisposition to a spectrum of tumourigenesis including phaeochromocytoma, paraganglioma (1) (PPGL), gastrointestinal stromal tumours (GIST) (2), renal cell carcinoma (RCC) (3) and pituitary adenomas (4). Pathogenic variants in each of the four genes (SDHx) encoding the four sub-components of this complex (SDHA/B/C/D) have been associated with tumourigenesis. Germline pathogenic variants in SDHB account for up to 50% of patients with malignant PPGL and a 5 year survival of less than 50% in those with malignancy (5). Most SDHx variant carriers require life long surveillance for tumour development (6) but predicting malignant disease is challenging and histology is of limited assistance in this prediction. The advent of next generation sequencing (NGS) has been influential in this field of inherited neoplasia allowing more rapid and accurate identification of pathogenic variants in the SDHx genes. However the increased throughput achieved with NGS methodology has yielded more variants of uncertain significance in these genes which require additional assessment. New diagnostic adjuncts such as SDHB immunohistochemistry(7), have provided additional prognostic information and prediction of malignant risk but further biomarkers are needed. Furthermore there is a lack of effective treatments for malignant disease associated with SDHx variants (8) (9). This 'multi-omics' investigation has provided new insights into genotype-phenotype correlations in SDH deficient disease and has facilitated the translation of new techniques into clinical utility which will aid SDHx variant interpretation. This study has evaluated novel disease biomarkers and potential therapeutic targets in SDH deficient tumours and has facilitated further progress in the pursuit of a precision medicine model of care for patients with rare inherited neoplasia syndromes.
Supervisor: Maher, Eamonn Sponsor: Health Research Board Ireland
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.774716  DOI:
Keywords: Phaeochromocytoma ; paraganglioma ; Succinate dehydrogenase ; metabolomics ; GIST
Share: